Clinical Trials Arena on MSN
Oticara’s nasal cream shows symptom improvement in Phase II trial
The study met its co-primary endpoints, demonstrating clinically meaningful improvements in both symptom scores.
A nasal spray might help healthy adults combat COVID-19, according to a study out of Germany. The news comes as coronavirus cases have recently started increasing again in the United States. As of Aug ...
The recommended dose of Atzumi is 5.2mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
I was addicted to Afrin nasal spray for a decade — I couldn’t breathe without it, how I finally quit
Get a whiff of this nightmare. A young woman struggled for years to breathe freely after becoming hooked on a popular over-the-counter nasal spray — making it nearly impossible to quit. “I could not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback